The Merit Medical Systems Inc (MMSI) share price is expected to increase by 12.2% over the next year. This is based on calculating the average 12-month share price estimate provided by 7 stock analysts who have covered MMSI. Price targets range from $81.00 at the low end to $102.00 at the high end. The current analyst consensus for MMSI is a buy. Please note analyst price targets are not guaranteed and could be missed completely.
Merit Medical Systems Inc has a total of 7 Wall St Analyst ratings. There are 5 buy ratings, 2 ratings, and 0 sell ratings. Since most analysts have a buy consensus rating, the expectation is that Merit Medical Systems Inc will outperform the market. Investors shouldn't rely purely on analyst ratings; we encourage investors to also take a look at the fundamental and technical analysis in their due diligence.
Analyst/Firm |
Rating |
Price Target |
Change |
Date |
---|---|---|---|---|
craig bijou Bank of America Securities | Hold | $87.0 | initiatedcoverage | Feb 7, 2024 |
michael petusky Barrington | Buy | $96.0 | maintained | Jan 26, 2024 |
john young cfa Canaccord Genuity | Buy | $102.0 | maintained | Jan 22, 2024 |
jason bednar Piper Sandler | Buy | $95.0 | rated | Jan 12, 2024 |
larry biegelsen Wells Fargo | Hold | $81.0 | maintained | Jan 11, 2024 |
michael matson Needham | Buy | $81.0 | reiterated | Jan 8, 2024 |
steven lichtman Oppenheimer | Buy | $82.0 | maintained | Dec 15, 2023 |
william plovanic Canaccord Genuity | Hold | $70.0 | maintained | Aug 28, 2023 |
jayson bedford Raymond James | Buy | $93.0 | maintained | May 8, 2023 |
matthew o'brien Piper Sandler | Buy | $79.0 | maintained | Jul 30, 2021 |
james sidoti Sidoti | Buy | $72.0 | maintained | Oct 29, 2020 |
cecilia furlong Morgan Stanley | Buy | $51.0 | maintained | Jul 30, 2020 |
bob hopkins Bank of America Securities | Sell | $30.0 | maintained | Oct 31, 2019 |
bruce nudell Truist Financial | Buy | $75.0 | reiterated | Nov 28, 2018 |
lawrence keusch Raymond James | Buy | $50.0 | reiterated | Mar 8, 2018 |
charles haff Craig-Hallum | Buy | $50.0 | reiterated | Jul 27, 2017 |
brooks west Piper Sandler | Buy | $27.0 | reiterated | Nov 30, 2016 |
thomas gunderson Piper Sandler | Buy | $22.0 | maintained | Feb 23, 2016 |
james terwilliger Northland Securities | Hold | $10.0 | initiatedcoverage | May 9, 2013 |
Merit Medical Systems, Inc. designs, develops, manufactures, and markets single-use medical products for interventional, diagnostic, and therapeutic procedures, primarily in cardiology, radiology, oncology, critical care, and endoscopy. It operates in two segments, Cardiovascular and Endoscopy. The company provides peripheral intervention products for the diagnosis and treatment of diseases in peripheral vessels and organs; and cardiac intervention products, such as access, angiography, electrophysiology and cardiac rhythm management, fluid management, hemodynamic monitoring, hemostasis, and intervention to treat various heart conditions. It also offers custom procedural solutions that include critical care products, disinfection protection systems, syringes, manifold kits, and trays and packs; coated tubes and wires; and sensor components for microelectromechanical systems. In addition, the company provides pulmonary products that consist of laser-cut tracheobronchial stents, over-the-wire and direct visualization delivery systems, and dilation balloons to endoscopically dilate strictures; gastroenterology products; and kits and accessories for endoscopy and bronchoscopy procedures. It sells its products to hospitals and alternate site-based physicians, technicians, and nurses through direct sales force, distributors, original equipment manufacturer partners, or custom procedure tray manufacturers in the United States and internationally. The company was incorporated in 1987 and is headquartered in South Jordan, Utah.
When did it IPO
0
Staff Count
6,846
Country
United States
Sector/Industry
Healthcare/Medical Instruments & Supplies
CEO
Mr. Fred P. Lampropoulos
Market Cap
$4.59B
In 2023, MMSI generated $0 in revenue, which was a increase of 0.00% from the previous year. This can be seen as a signal that MMSI's business is growing, and its share price could be worth more in the future. However, if the company grows faster (or slower) than expected, this could also have a major impact on the future share price.
Revenue From 2019
Revenue From 2020
Revenue From 2021
Revenue From 2022
$233.13
FELE-USD
$98.07
RCM-USD
$10.87
HCP-USD
$22.69
$34.55
COOP-USD
$72.4